| Literature DB >> 17470365 |
Jeong-A Kim1, Sungyoul Hong, Byungsun Lee, Jong Wook Hong, Jae-Yong Kwak, Scott Cho, Chun-Choo Kim.
Abstract
Mesenchymal stem cells (MSCs) have been shown to down-regulate T-cell responses. However, the mechanisms underlying remain unknown. In this study, we report that BALB/c bone marrow-derived MSCs inhibit the proliferation of allogeneic T-cells in mixed lymphocyte reactions (MLR), This inhibition is dependent on cell-cell contact, and do not induce apoptosis. Furthermore, cell-cycle analyses reveal that T-cells, in the presence of MSCs, are arrested in the G0/G1 phase through. The blockage of phosphorylation of retinoblastoma protein (Rb), mediated by the p16(INK4A)-cyclin D1/cdk4 complex and p21(waf1), p27(kip1)-cyclin E/cdk2 complex pathway. Our results suggest that MSCs may perform a crucial function in the maintenance of immune homeostasis, via direct regulation of the clonal expansion of activated T-cells. The novel T-cell regulatory mechanism exhibited by MSCs may prove useful in a variety of therapeutic applications.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17470365 DOI: 10.1016/j.cellimm.2007.03.003
Source DB: PubMed Journal: Cell Immunol ISSN: 0008-8749 Impact factor: 4.868